This tri‐modality therapy resulted in an increase in the number of tumor‐infiltrating CD8+ T cells, activation of NK cells, enhancement in secretion of cytokines such as IL‐12 and TNF‐α, a tumor inhibition rate of 84.2%, and effective restraint of the lung metastasis.[184]. This evidence concerns the gene CD8A and neoplasm.